Related Experiment Video
Updated: Jul 30, 2026

10:29
Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model
Published on: August 29, 2012
15.8K
Mycophenolate mofetil-induced colitis versus colonic graft-versus-host disease: a comparative histologic study with
Rofyda Elhalaby1,2, Priyadharshini Sivasubramaniam3, Benjamin J Van Treeck1,4
1Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Histopathology
|July 24, 2025
Summary
This study differentiated MMF-induced colitis from GVHD using histopathology and AI. Lower eosinophil counts and higher apoptotic counts favor GVHD, aiding diagnosis in transplant patients.
Area of Science:
- Gastroenterology
- Hematology
- Pathology
Background:
- Distinguishing Mycophenolate Mofetil (MMF)-induced colitis from Graft-versus-Host Disease (GVHD) is crucial in transplant patients.
- Histopathologic features are key, but objective quantification of specific cell types like eosinophils can be challenging.
Purpose of the Study:
- To compare the histopathologic features of MMF-induced colitis and colonic GVHD.
- To develop and validate a deep learning model for semi-automated eosinophil quantification in the colon.
Main Methods:
- Retrospective review of MMF-induced colitis and GVHD cases.
- Histologic features were analyzed, including apoptotic counts and neuroendocrine aggregates.
- A deep learning convolutional neural network (CNN) was trained to quantify lamina propria eosinophils.
Main Results:
- GVHD cases showed significantly higher apoptotic counts compared to MMF-induced colitis.
- Neuroendocrine aggregates were observed in GVHD but not in MMF-induced colitis.
- The deep learning CNN identified significantly higher eosinophil counts in MMF-induced colitis compared to GVHD.
Conclusions:
- Lower eosinophil counts, higher apoptotic counts, and presence of neuroendocrine aggregates favor GVHD.
- AI-powered eosinophil quantification can serve as an ancillary tool for differential diagnosis.
- A high threshold for diagnosing MMF-induced colitis is recommended in stem cell transplant patients due to its rarity.

